Dementia in Lewy body diseases (LBD) is common and arises through heterogeneous and incompletely understood pathways. Evidence suggests contributions from genetic factors, including APOE ε4 genotype, co-pathology including concomitant Alzheimer's disease pathology and hypoperfusion related to orthostatic hypotension. However, the relative impact of these factors remains unclear. To address this, we analysed 399 post-mortem brains from LBD cases comprising Parkinson's disease, Parkinson's disease
Quantitative pathology and APOE genotype reveal dementia risk and progression in Lewy body disease
Hemanth R. Nelvagal·Zane Jaunmuktane·Toby J Curless·Patrick W. Cullinane·Alice Rockliffe·Samarth Pimparkar·Haruka Kawamura·Sophie Ollerenshaw·Isha Elahi·Sebastian Brandner·Lesley Wu·Raquel Real·Mina Ryten·John Hardy·Eduardo de Pablo Fernández·Thomas T. Warner·Huw R Morris·Yau Mun Lim·Nancy Chiraki
